DTIL

7.4007.09%
SL

Shari Lisa Pire

Independent Director

Ms. Shari Lisa Piré, J.D. serves as Chief Legal Officer of Plume Design, Inc and served as its Chief Sustainability Officer since July 2022 until February 2025 and serves as its Chief Privacy Officer since February 2025. She serves as an Independent Director at Precision BioSciences, Inc. since November 2021. She had been Chief Legal Officer at Cognate BioServices, Inc. since 2015. Ms. Piré joined Cognate in 2015. A seasoned attorney and member of the Cognate senior management team, she is fully engaged in the resolution of a wide range of legal and general management issues. Leading all of the legal and corporate affairs of Cognate and its affiliates, Ms. Piré, develops, directs and advises the Board and the Chief Executive Officer, Chief Operating Officer, Chief Financial Officer and other executives on all legal and strategic matters. More specifically, she implements and manages all legal aspects of Cognate’s business including its growth strategy, acquisitions, manufacturing and development activities. She is further responsible for addressing regulatory matters (including FDA and cGMP matters) and for the strategy, maintenance and prosecution of its global patent portfolio and all litigation involving the company. Ms. Piré also provides a full sepectrum of legal services to Cognate’s partners and affiliates, including entities engaged in the development of immunotherapies and related products and services for the regenerative medicine industry. Prior to joining Cognate, Ms. Piré gained extensive experience at Skadden, Arps, Slate, Meagher & Flom, LLP and Willkie Farr & Gallagher LLP, practicing for more than a decade in New York and five years in Paris, France, during which time she represented public and private companies operating in a variety of industries and geographies on a wide spectrum of corporate matters, including both foreign and domestic mergers, acquisitions, divestitures and private equity financings. While at Skadden, in New York City and Paris, France, Ms. Piré’s clients leveraged her experience for their most complex cross-border deals. At Willkie, Ms. Piré expanded the scope of her representations to include corporate and financial transactions more broadly while continuing to focus on representing businesses operating in big pharma, biotech, hi-tech and telecom. Currently, Ms. Piré is the Chief Legal & Sustainability Officer at Plume Design, Inc. During her tenure, Ms. Piré also served as a board member to Cobra Biologics Ltd. a wholly owned gene therapy-focused CDMO that Cognate acquired under her leadership. She serves on the Board of Directors of the Academie Americaine de Danse de Paris. Ms. Piré holds a B.A. in French Literature from the University of California at Irvine and a J.D. magna cum laude, from New York Law School. Ms. Piré served as Editor of the New York Law School Law Review and is admitted to the New York and D.C. Bars. Ms. Piré also serves on two non-profit boards of directors focused on children’s underserved medical needs and pediatric healthcare, respectively.

Positions